Literature DB >> 30046571

Ablative therapies for intrahepatic cholangiocarcinoma.

Antonio Giorgio1, Pietro Gatti2, Paolo Matteucci3, Valentina Giorgio4.   

Abstract

Entities:  

Year:  2018        PMID： 30046571      PMCID： PMC6036070          DOI： 10.21037/hbsn.2018.02.06

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  15 in total

Review 1.  Ablative therapies for intrahepatic cholangiocarcinoma.

Authors:  Junichi Shindoh
Journal:  Hepatobiliary Surg Nutr       Date:  2017-02       Impact factor: 7.293

2.  Intrahepatic cholangiocarcinoma: expert consensus statement.

Authors:  Sharon M Weber; Dario Ribero; Eileen M O'Reilly; Norihiro Kokudo; Masaru Miyazaki; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

Review 3.  Epidemiology and risk factors: intrahepatic cholangiocarcinoma.

Authors:  Amar Gupta; Elijah Dixon
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

4.  Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma.

Authors:  H-X Xu; Y Wang; M-D Lu; L-N Liu
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

5.  Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma.

Authors:  Yi-You Chiou; Jen-I Hwang; Yi-Hong Chou; Hsin-Kai Wang; Jen-Huey Chiang; Cheng-Yen Chang
Journal:  Kaohsiung J Med Sci       Date:  2005-07       Impact factor: 2.744

6.  Contrast-Enhanced Ultrasound: a Simple and Effective Tool in Defining a Rapid Diagnostic Work-up for Small Nodules Detected in Cirrhotic Patients during Surveillance.

Authors:  Antonio Giorgio; Luca Montesarchio; Piero Gatti; Ferdinando Amendola; Paolo Matteucci; Bruno Santoro; Maria Gabriella Merola; Francesca Merola; Carmine Coppola; Valentina Giorgio
Journal:  J Gastrointestin Liver Dis       Date:  2016-06       Impact factor: 2.008

7.  Comparison of clinicopathological characteristics between cirrhotic and non-cirrhotic patients with intrahepatic cholangiocarcinoma: A large-scale retrospective study.

Authors:  Lei Yuan; Xianwu Luo; Xinyuan Lu; Bin Yi; Kaijian Chu; Quanyu Cai; Xiaoqing Jiang
Journal:  Mol Clin Oncol       Date:  2017-08-22

8.  Clinical and survival outcomes of percutaneous microwave ablation for intrahepatic cholangiocarcinoma.

Authors:  Kai Zhang; Jie Yu; Xiaoling Yu; Zhiyu Han; Zhigang Cheng; Fangyi Liu; Ping Liang
Journal:  Int J Hyperthermia       Date:  2017-05-19       Impact factor: 3.914

9.  Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results.

Authors:  Guido Poggi; Benedetta Montagna; Pamela DI Cesare; Giulia Riva; Giovanni Bernardo; Mauro Mazzucco; Alberto Riccardi
Journal:  Anticancer Res       Date:  2013-03       Impact factor: 2.480

10.  Percutaneous microwave ablation combined with simultaneous transarterial chemoembolization for the treatment of advanced intrahepatic cholangiocarcinoma.

Authors:  Guo-Wei Yang; Qing Zhao; Sheng Qian; Liang Zhu; Xu-Dong Qu; Wei Zhang; Zhi-Ping Yan; Jie-Min Cheng; Qing-Xin Liu; Rong Liu; Jian-Hua Wang
Journal:  Onco Targets Ther       Date:  2015-05-26       Impact factor: 4.147
View more
  1 in total

1.  The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-Analysis.

Authors:  Gang Xu; Lejia Sun; Yunzhu Li; Feihu Xie; Xiaoxiang Zhou; Huayu Yang; Shunda Du; Haifeng Xu; Yilei Mao
Journal:  Front Oncol       Date:  2019-09-18       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.